
    
      Our hypothesis is that the intra-articular administration of dexamethasone soon after joint
      injury will prevent the subsequent development of PTOA, and restore normal joint homeostasis.
      We plan to generate the data needed to test this hypothesis in a Phase 0 (pilot) clinical
      trial using patients who have suffered distal radius fractures.
    
  